Meeder Asset Management Inc Kezar Life Sciences, Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.44 - $16.72 $44,706 - $100,470	-6,009 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$4.85 - $9.73 $29,143 - $58,467	6,009 New	6,009 $53,000
Q4 2020 Feb 09, 2021	SELL	$4.77 - $6.58 $825 - $1,138	-173 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$3.6 - $7.75 $2,692 - $5,797	-748 Reduced 81.22%	173 $0
Q1 2020 May 15, 2020	BUY	$2.77 - $5.75 $307 - $638	111 Added 13.7%	921 $3,000
Q4 2019 Feb 13, 2020	BUY	$2.5 - $4.26 $90 - $153	36 Added 4.65%	810 $3,000
Q3 2019 Oct 17, 2019	BUY	$3.0 - $7.58 $2,322 - $5,866	774 New	774 $3,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.